Skip to content
10-Q

Quarterly Report

Boundless Bio, Inc. BOLD

0000950170-25-067496

← back to feed
Filed
May 9, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 6, 2025 22.39M sh
Short Term Investments Q1 2025 · Mar 31, 2025 $123.14M
Short Term Investments Q1 2025 · Dec 31, 2024 $125.53M
Stockholders Equity Q1 2025 · Mar 31, 2025 $136.59M
Stockholders Equity Q1 2025 · Dec 31, 2024 $150.64M
Current Liabilities Q1 2025 · Mar 31, 2025 $6.34M
Current Liabilities Q1 2025 · Dec 31, 2024 $8.14M
Total Liabilities Q1 2025 · Mar 31, 2025 $54.65M
Total Liabilities Q1 2025 · Dec 31, 2024 $55.77M
Current Assets Q1 2025 · Mar 31, 2025 $140.36M
Current Assets Q1 2025 · Dec 31, 2024 $154.39M
Total Assets Q1 2025 · Mar 31, 2025 $191.24M
Total Assets Q1 2025 · Dec 31, 2024 $206.41M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $26.59M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $25.14M
Shares Diluted Q1 2025 · Mar 31, 2024 1.26M sh
Capex Q1 2025 · Mar 31, 2024 $83K
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$15.78M
Eps Diluted Q1 2025 · Mar 31, 2024 −$12.27
Eps Basic Q1 2025 · Mar 31, 2024 −$12.27
Sga Expense Q1 2025 · Mar 31, 2024 $3.75M
Rd Expense Q1 2025 · Mar 31, 2024 $13.13M
Net Income Q1 2025 · Mar 31, 2024 −$15.43M
Operating Income Q1 2025 · Mar 31, 2024 −$16.88M